Phase 2 Sleep Disorders Trial, Recruiting (NCT06587256)

Phase 2 Sleep Disorders Trial, Recruiting NCT06587256 Sponsor: Johns Hopkins University Condition: Sleep Disorders

Printed from Voxsanity (voxsanity.com.au) — NCT06587256 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Sleep Disorders

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Adults with a Body Mass Index (BMI) of 35 or higher who report that they snore
People who have a bed partner able to answer questions about their snoring
People who have already had a sleep study showing either no sleep apnea, or only mild sleep apnea (meaning the sleep study recorded fewer than 15 breathing interruptions per hour)

Who may not be able to join:

People who are allergic to silicone mouth tape
People with a chronic (long-term) lung disease
People with facial hair that would prevent mouth tape from sticking properly
People with significantly enlarged tonsils (Grade 3 or higher, confirm with trial site)
People who have previously had surgery on the roof of the mouth (palate) or tongue
People who have any condition that causes them to under-breathe, either long-term or short-term
People who are unable to comfortably breathe through their nose while wearing the mouth tape for at least 3 minutes
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 20 July 2026

Phase 2: approximately ~30% of drugs entering this phase reach regulatory approval, based on published industry-wide historical data. This is not specific to this trial.

Phase success rates shown are historical industry-wide averages based on published data. They are not a prediction for this specific trial or your individual situation.

Contact this trial

Principal Investigator: Jonathan Jun, MD, Johns Hopkins University

Phone: 410-550-2233

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06587256

Sponsor: Johns Hopkins University

Phase: Phase 2

Status: Recruiting

Condition: Sleep Disorders

Trial contact: 410-550-2233

More information: https://clinicaltrials.gov/study/NCT06587256

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Adults with a Body Mass Index (BMI) of 35 or higher who report that they snore
People who have a bed partner able to answer questions about their snoring
People who have already had a sleep study showing either no sleep apnea, or only mild sleep apnea (meaning the sleep study recorded fewer than 15 breathing interruptions per hour)

Who may not be able to join:

People who are allergic to silicone mouth tape
People with a chronic (long-term) lung disease
People with facial hair that would prevent mouth tape from sticking properly
People with significantly enlarged tonsils (Grade 3 or higher, confirm with trial site)
People who have previously had surgery on the roof of the mouth (palate) or tongue
People who have any condition that causes them to under-breathe, either long-term or short-term
People who are unable to comfortably breathe through their nose while wearing the mouth tape for at least 3 minutes
People who are pregnant

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 20 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Phase 2

Sponsor

Johns Hopkins University

Registry

ClinicalTrials.gov

Start date

1 March 2027

Est. completion

1 October 2030

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Snoring / Sleep Survey (SSS)

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov